Electron Transport Chain: Complex I and II
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Receptor Downregulation in MVBs
mTOR Signaling and Cancer Progression
Regulation of Angiogenesis and Blood Supply
您也可能阅读
通过共同作者、期刊和引用图与本文相关的文章。
Updated: May 31, 2025

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
Yao Qu1, Zhi-Xue Liu2, Xiao-Xu Zheng2
1Department of Cardiology, Harbin Medical University Cancer Hospital, NHC Key Laboratory of Cell Transplantation, Department of Cardiology, Central Laboratory, The First Affiliated Hospital of Harbin Medical University, Institute of Metabolic Disease, Heilongjiang Academy of Medical Sciences, Heilongjiang Key Laboratory for Metabolic Disorder & Cancer Related Cardiovascular Diseases, Key Laboratories of Education Ministry for Myocardial Ischemia Mechanism and Treatment, State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Harbin, China; Center for Molecular and Translational Medicine, Georgia State University, Atlanta, USA.
像苏尼蒂尼布这样的氨酸激酶抑制剂通过损害内皮细胞线粒体和减少与线粒体相关的内细胞网膜 (MAMs) 来引起高血压. 恢复MAMs功能可能是对抗这种副作用的治疗策略.
08:15Exploring Mitochondrial Energy Metabolism of Single 3D Microtissue Spheroids Using Extracellular Flux Analysis
Published on: February 3, 2022
07:05TGF-β-mediated Endothelial to Mesenchymal Transition EndMT and the Functional Assessment of EndMT Effectors using CRISPR/Cas9 Gene Editing
Published on: February 26, 2021
科学领域:
背景情况:
研究的目的:
主要方法:
主要成果:
结论: